LOXL2 and pancreatic neoplasm: The molecular details of how tamoxifen decreases collagen organisation in the breast have not been investigated here, but preclinical data from a mouse pancreatic cancer model suggest that tamoxifen reduces collagen content and organisation in a lysyl oxidase-like 2 (LOX-L2)-dependent manner [45].